skip to main content
Marian-Wolanski-isolated

Marian Wolanski

Direct: 416.863.3355
Fax: 416.863.9171
Email: marian.wolanski@belmorelaw.com

Marian Wolanski is a partner at Belmore Neidrauer LLP.  Marian practices intellectual property litigation, with a focus on pharmaceutical and biotechnology patent disputes and Patented Medicines (Notice of Compliance) proceedings.  Marian has appeared as counsel in the Federal Court and Federal Court of Appeal.  Marian’s practice also includes providing freedom to operate and patent validity opinions.

Marian was called to the Ontario bar in 2008.  While attending law school at the University of Windsor, Marian completed a clerkship at the Provincial Court and was the managing editor of the Windsor Review of Legal and Social Issues.  

Marian also has a technical background in the life sciences area and has co-authored several publications in scientific journals.  Marian earned a B.Sc.H. (Genetics) from the University of Western Ontario.  She also earned a M.Sc. degree and worked as a research associate in the area of molecular biology at the University of Windsor.

Education

  • Called to the Ontario Bar, 2008
  • University of Windsor, LL.B., 2007
  • University of Windsor, M.Sc. (Molecular Biology), 2004
  • University of Western Ontario, B.Sc.H. (Genetics), 2000

Awards

Publications

Date Title Type
Jan 01, 2012 “Initial Steps in the Regulation of Generic Biological Drugs: A Comparison of U.S. and Canadian Regimes” 67(2) Food and Drug Journal 131 (2012) Biological drug products are poised to overtake traditional pharmaceuticals as the best selling products in the pharmaceutical industry. Accordingl... Article
Dec 01, 2011 Intellectual Property in the Life Sciences, Canada Chapter 2011 A Global Guide to Rights and Their Applications (Globe Business Publishing Ltd 2011) Book
Aug 01, 2006 Co-author, “Patented Medicines (Notice of Compliance) Regulations” in Adrienne M. Blanchard & Jane B.H. Steinberg, Life Sciences Law in Canada, looseleaf (Thomson Carswell, August 2006) Book

Cases

Date Case Title Expertise
Jan 20, 2017 2016 FC 1361 Janssen Inc. et al. v. Actavis Pharma Company et al.
We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA.  The generic company Actavis Pharma had challen...

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited
We obtained damages in excess of $18M for Teva’s infringement of a patent covering Janssen’s LEVAQUIN product.

Patents

Sep 16, 2015 2015 FCA 192 Actavis Pharma Company v. Alcon Canada Inc.
We successfully resisted Actavis’ appeal of the trial judge’s finding that the basic compound patent protecting VIGAMOX was valid.

Patents

Oct 28, 2014 2014 FCA 242 Janssen Inc. v. Abbvie Corporation
We successfully represented Janssen on this appeal from a refusal to grant an amendment to Janssen’s pleading.  The Court of Appeal agre...

Patents

May 14, 2014 2014 FC 462 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company
We successfully defended the validity of Bayer’s key patent covering the anti-infective moxifloxacin (AVELOX® and VIGAMOX ®) and obta...

Patents

Affiliations

  • Intellectual Property Institute of Canada (IPIC), Member of Editorial Board of the Canadian Intellectual Property Review
Marian-Wolanski-isolated

Marian Wolanski 

Partner

Direct: 416.863.3355
Fax: 416.863.9171
Email: marian.wolanski@belmorelaw.com

Assistant
Melanie Carman
Direct: 416.863.3382T 416.863.3382
Email: melanie.carman@belmorelaw.com

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy